Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eden

Showing results (211-220 of 286) with videos related to

Pageof 29
Sort By:
Journal of Dual Diagnosis|June 28, 2022
Implementing Chronic Care Model Treatments for Cigarette Dependence in Community Mental Health ClinicsSandra J Japuntich, Melissa Adkins-Hempel, Carina Lundtvedt, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 28, 2011
Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcomeYasmin Mashhoon, Amy C Janes, J Eric Jensen, et al.
Journal of General Internal Medicine|March 9, 2019
Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES TrialRobert M Anthenelli, Michael Gaffney, Neal L Benowitz, et al.
Psychopharmacology|October 27, 2004
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patientsDonald C Goff, Lawrence Herz, Thomas Posever, et al.
Acta Psychiatrica Scandinavica|February 3, 2009
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophreniaD C Henderson, X Fan, B Sharma, et al.
Addiction (Abingdon, England)|March 7, 2018
Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLESRobert West, A Eden Evins, Neal L Benowitz, et al.
JAMA Network Open|December 12, 2025
Cannabis Use and Nicotine Vaping Cessation Outcomes: A Secondary Analysis of a Randomized Clinical TrialJodi M Gilman, Corinne Cather, Harrison T Reeder, et al.
JAMA Network Open|July 30, 2025
State E-Cigarette Flavor Restrictions and Tobacco Product Use in Youths and AdultsDavid Cheng, Boram Lee, Abra M Jeffers, et al.
Maturitas|September 16, 2000
Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapiesH A Verheul, H J Coelingh-Bennink, P Kenemans, et al.
Journal of Clinical Psychopharmacology|February 28, 2019
Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES TrialA Eden Evins, Neal L Benowitz, Robert West, et al.
Pageof 29

Showing results (211-220 of 286) with videos related to

Sort By:
Pageof 29
Journal of Dual Diagnosis|June 28, 2022
Implementing Chronic Care Model Treatments for Cigarette Dependence in Community Mental Health ClinicsSandra J Japuntich, Melissa Adkins-Hempel, Carina Lundtvedt, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 28, 2011
Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcomeYasmin Mashhoon, Amy C Janes, J Eric Jensen, et al.
Journal of General Internal Medicine|March 9, 2019
Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES TrialRobert M Anthenelli, Michael Gaffney, Neal L Benowitz, et al.
Psychopharmacology|October 27, 2004
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patientsDonald C Goff, Lawrence Herz, Thomas Posever, et al.
Acta Psychiatrica Scandinavica|February 3, 2009
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophreniaD C Henderson, X Fan, B Sharma, et al.
Addiction (Abingdon, England)|March 7, 2018
Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLESRobert West, A Eden Evins, Neal L Benowitz, et al.
JAMA Network Open|December 12, 2025
Cannabis Use and Nicotine Vaping Cessation Outcomes: A Secondary Analysis of a Randomized Clinical TrialJodi M Gilman, Corinne Cather, Harrison T Reeder, et al.
JAMA Network Open|July 30, 2025
State E-Cigarette Flavor Restrictions and Tobacco Product Use in Youths and AdultsDavid Cheng, Boram Lee, Abra M Jeffers, et al.
Maturitas|September 16, 2000
Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapiesH A Verheul, H J Coelingh-Bennink, P Kenemans, et al.
Journal of Clinical Psychopharmacology|February 28, 2019
Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES TrialA Eden Evins, Neal L Benowitz, Robert West, et al.
Pageof 29